These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 9114905
1. The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. Macdonald NJ, Sioufi A, Howie CA, Wade JR, Elliott HL. Br J Clin Pharmacol; 1993 Sep; 36(3):205-9. PubMed ID: 9114905 [Abstract] [Full Text] [Related]
2. A comparison in young and elderly subjects of the pharmacokinetics and pharmacodynamics of single and multiple doses of benazepril. Macdonald NJ, Elliott HL, Hughes DM, Reid JL. Br J Clin Pharmacol; 1993 Sep; 36(3):201-4. PubMed ID: 9114904 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs. King JN, Mauron C, Kaiser G. Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524 [Abstract] [Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly. Kaiser G, Ackermann R, Dieterle W, Durnin CJ, McEwen J, Ghose K, Richens A, Holmes IB. Eur J Clin Pharmacol; 1990 Dec; 38(4):379-85. PubMed ID: 2344861 [Abstract] [Full Text] [Related]
6. Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl. King JN, Humbert-Droz E, Maurer M. J Vet Pharmacol Ther; 1999 Dec; 22(6):360-7. PubMed ID: 10651464 [Abstract] [Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses. Gómez-Díez M, Muñoz A, Caballero JM, Riber C, Castejón F, Serrano-Rodríguez JM. Res Vet Sci; 2014 Aug; 97(1):105-10. PubMed ID: 24972864 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog. King JN, Maurer M, Morrison CA, Mauron C, Kaiser G. Xenobiotica; 1997 Aug; 27(8):819-29. PubMed ID: 9293618 [Abstract] [Full Text] [Related]
14. Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets. Moffett BS, DiSanto AR, Espinosa O, Hou J, Colabuono P. Clin Pharmacol Drug Dev; 2014 Nov; 3(6):493-8. PubMed ID: 27129124 [Abstract] [Full Text] [Related]
17. The pharmacokinetics of benazepril relative to other ACE inhibitors. Gengo FM, Brady E. Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV44-50; discussion IV51-5. PubMed ID: 1893642 [Abstract] [Full Text] [Related]
18. Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril. Louis WJ, Conway EL, Krum H, Workman B, Drummer OH, Lam W, Phillips P, Howes LG, Jackson B. Clin Exp Pharmacol Physiol Suppl; 1992 Aug; 19():55-60. PubMed ID: 1327596 [Abstract] [Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of benazepril hydrochloride in patients with major proteinuria. Schweizer C, Kaiser G, Dieterle W, Mann J. Eur J Clin Pharmacol; 1993 Aug; 44(5):463-6. PubMed ID: 8359184 [Abstract] [Full Text] [Related]
20. Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses. Serrano-Rodríguez JM, Gómez-Díez M, Esgueva M, Castejón-Riber C, Mena-Bravo A, Priego-Capote F, Ayala N, Caballero JMS, Muñoz A. Res Vet Sci; 2017 Oct; 114():117-122. PubMed ID: 28371693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]